All the news Showing 6 of 696 articles from: Treatment issuesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources New drugs take aim at hepatitis C, spur debate on whether to test baby boomers Canadian Press / 18 January 2011 Peregrine Initiates Randomized Phase II Trial of Bavituximab in Chronic Hepatitis C Market Wire / 10 January 2011 Bristol-Myers Squibb and Pharmasset Enter into a Clinical Collaboration Agreement for Proof of Concept Combination Study in Patients Chronically Infected with Hepatitis C Business Wire / 10 January 2011 Merck Beats Vertex to FDA Hep C Filing The Street / 07 January 2011 Pharmasset Reports Positive Results from its HCV Clinical Programs Pharmasset / 06 January 2011 Anadys Pharmaceuticals Initiates Phase IIb Study of ANA598 in HCV Patients PR Newswire / 05 January 2011 ← Prev1...6667686970Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive